癌症的进化理论:挑战和潜在的解决方案
Lucie Laplane1,2, Carlo C Maley3,4,5,6
1UMR 8590 Institut d'Histoire et Philosophie des Sciences et des Techniques, CNRS, University Paris I Pantheon-Sorbonne, Paris, France.
Nature reviews. Cancer
|September 10, 2024
概括
癌症生物学中的克隆进化模型需要更新. 这项研究确定了其理论限制,并提出了整合复杂癌症动态的解决方案,从而改善我们对癌症进展的理解.
科学领域:
- 癌症生物学 癌症生物学
- 进化生物学 进化生物学
- 遗传学 遗传学是一种遗传学.
背景情况:
- 克隆进化模型是癌症生物学中的核心,它面临着来自表型可塑性和非遗传遗传的挑战.
- 现有的模型在与非树状基因传播和定义癌症克隆作斗争.
- 该模型的实用性取决于其解释癌症进化过程的能力.
研究的目的:
- 为了解决围绕癌症克隆的定义模两可.
- 确定当前克隆进化模型中的理论局限性.
- 提出解决方案,将复杂的癌症动态纳入现有框架.
主要方法:
- 克隆进化模型性能的理论分析.
- 鉴定癌症复杂性所带来的经验挑战.
- 开发策略来增强模型的解释能力.
主要成果:
- 克隆进化模型具有理论上的性能限制.
- 现型可塑性和非遗传因素挑战了传统的模型.
- 一个精细的模型可以结合复杂的癌症动态.
结论:
- 克隆进化模型需要更新,以充分涵盖癌症的复杂性.
- 整合非遗传因素和多样化的传播模式增强了模型.
- 这项工作为更全面地了解癌症演变提供了一条道路.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer
48.2K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.2K
Cancers Originate from Somatic Mutations in a Single Cell
11.8K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.8K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer-Critical Genes I: Proto-oncogenes
8.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334


